Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors.
暂无分享,去创建一个
P. Gallant | M. Morrison | P. Rose | A. Polverino | M. Emery | S. Bellon | B. Albrecht | Joseph L. Kim | Stephanie D. Geuns-Meyer | S. Caenepeel | A. Long | Paul E Hughes | Sean Caenepeel | Yan Gu | Huilin Zhao | Vinod F Patel | Anthony Polverino | V. Patel | Alexander M Long | Yan Gu | Joseph L Kim | Brian L Hodous | Stephanie D Geuns-Meyer | Brian K Albrecht | Steve Bellon | Victor J Cee | Stuart C Chaffee | Maurice Emery | Jenne Fretland | Paul Gallant | Rebecca E Johnson | Michael Morrison | Philip R Olivieri | Paul Rose | Ling Wang | Huilin Zhao | P. Hughes | V. Cee | S. Chaffee | Rebecca E. Johnson | Brian L. Hodous | P. Olivieri | Ling Wang | J. Fretland
[1] J Folkman,et al. Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.
[2] J. Folkman,et al. Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.
[3] M. Webb,et al. Discovery and Characterization of Triaminotriazine Aniline Amides as Highly Selective p38 Kinase Inhibitors , 2006, Journal of Pharmacology and Experimental Therapeutics.
[4] Richard Kendall,et al. Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor. , 2007, Journal of medicinal chemistry.
[5] Lars Holmgren,et al. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.
[6] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[7] Richard A. Lang,et al. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] Sung Hyun Kim,et al. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] H. Augustin,et al. The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism , 2005, Journal of Cell Science.
[10] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[11] J. Cheetham,et al. An Automated Screening Assay for Determination of Aqueous Equilibrium Solubility Enabling SPR Study During Drug Lead Optimization , 2005 .
[12] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[13] Hui Chen,et al. Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase. , 2003, Journal of medicinal chemistry.